Boehringer Mannheim Gmbh

Roche Diagnostics Gmbh

Roche Diagnostics Operations, Inc.

Mark J Simmons

Karl Szabo

Richard O Carmack

Charles V Green

G Scott Rulong

Stephen T West

Frank W Wagle

David S Herron

Darren Carl Martin

Raymond E Szkotak

Robert C Uleski

Howard Clarence Freeman

Li-Wun Chen Tam

Frederic Furrer

Laurian I Rusu

Yih-Shiong Wu

Jeanne Bohannon

Kamran Akhavan

Yolanda White

Gary K Scarr

Dale L Wedel

A three dimensional chess game method and apparatus which features four levels, one square, non-playing surface baseboard and four square sub-levels, one quarter the size of the baseboard, adjacent and above the base board at various heights. Sub-levels are divided into sixteen squares, by combining the squares from all of the sub-levels there are sixty-four possible playing positions. The King, queen, bishop and knight acquire three dimensional movement by using the height difference between sub-levels, and using square placement on each sub-levels as equal, when the king, queen, or bishop land on a square on any sub-level, all sub-levels holds a virtual playing piece on that square location. Three dimensional movement is obtained through rotation around center point of the chess board as the piece moves from sub-level to sub-level and X, Y and Z, movements between sub-levels which is utilized by the knight.

Chess M.D. (multi-dimensional)

A g-force-sensitive label for detecting and indicating the application of a g-force is provided, the g-force sensitive label comprising an area for detecting and indicating an application of a g-force above a threshold value on the g-force sensitive label and an attachment area for attaching the g-force sensitive label on an object. At least one physical property of the area measurably changes its state upon applying a g-force above the threshold value, thereby altering a displayed pattern such that a machine-readable 1D or 2D or alphanumeric code is displayed.

G-force sensitive label and corresponding sample tube, method and analytical system

A method and apparatus for analyzing the results of determinations of the concentrations of medically significant components of control solutions comprise providing a programmable machine, executing on the machine a program which tests the results against a set of statistical quality control rules, and producing indications to an operator of the results of the tests. Illustratively, (a) laboratory analytical instrument(s) run(s) the control solutions interspersed among patient samples, the concentrations of medically significant components of which are determined by the laboratory instrument(s). The quality of the laboratory instrument's(s') process(es) for determining the concentrations of the medically significant components of the patient samples are monitored by testing the outcomes of the concentration determinations of the control solutions against the set of QC rules. The QC testing process is conducted as the concentrations of the medically significant components of the control solutions are determined, so that delays between the determination of the concentrations of the medically significant components of the patient samples and the determination of the state of control of the process(es) by which those concentrations are determined are minimized.

Multi-rule quality control method and apparatus

A method and apparatus for providing communication between a first machine and a second machine comprises the steps of, and apparatus for, coupling a first video display output of the first machine to a first input port of the second machine, converting first video display signals generated by the first machine at the first video display output into first instructions and data and using the first instructions and data to operate the second machine.

Method and apparatus for automatic control of instruments through video

A system and method provide for distinguishing among characters of a character set. The characters are represented by a data stream of pixel information to a display port. A subset of the pixel information in the data stream contains sufficient information for unique identification of each character within the character set. Examination of the data within the subset of pixels permits identification of respective characters within the set.

Novel reagent compositions and an assay method for the measurement of total and direct bilirubin are disclosed. The reagent compositions comprise an aqueous solution of at least one betaine selected from the group of alkyl betaine, betaine and betaine hydrate, a sulfanilamide diazonium salt, iodide ions and sulfamic acid. In the measurement of total bilirubin, alkyl betaine serves as an accelerator/solubilizer for the reaction of unconjugated bilirubin, and the alkyl betaine, betaine or betaine hydrate, together with iodide ions, minimizes or substantially eliminates interference from hemoglobin and lipemia.

Assay for total and direct billirubin

Growing community of inventors

Carmel, IN, United States of America

Mark J Simmons